These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7847809

  • 21. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.
    Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621
    [Abstract] [Full Text] [Related]

  • 22. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ, Torosantucci A, Quinti I, Testa U, Peschle C, Cassone A.
    Cell Immunol; 1993 Dec 01; 152(2):530-43. PubMed ID: 8258154
    [Abstract] [Full Text] [Related]

  • 23. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY, Uchida H, Iwaki K, Kai S, Shibata K, Ohta M, Kitano S.
    Gan To Kagaku Ryoho; 2007 Jun 01; 34(6):957-9. PubMed ID: 17565266
    [Abstract] [Full Text] [Related]

  • 24. Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
    Shang D, Ito N, Watanabe J, Awakura Y, Nishiyama H, Kamoto T, Ogawa O.
    Eur Urol; 2007 Oct 01; 52(4):1131-9. PubMed ID: 17275163
    [Abstract] [Full Text] [Related]

  • 25. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A, Pelin K, Halme M, Ekman A, Mattson M, Vallas M, Mattson K, Linnainmaa K, Husgafvel-Pursiainen K.
    Anticancer Drugs; 1993 Jun 01; 4(3):365-8. PubMed ID: 8395259
    [Abstract] [Full Text] [Related]

  • 26. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
    Lovgren TR, Tarantolo SR, Evans C, Kuszynski CA, Joshi SS.
    In Vivo; 2002 Jun 01; 16(6):541-50. PubMed ID: 12494899
    [Abstract] [Full Text] [Related]

  • 27. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
    De Filippi R, Fuggetta MP, Ricci F, Marini S, Caliendo R, Giuliani A.
    Chemioterapia; 1987 Dec 01; 6(6):410-6. PubMed ID: 2449291
    [Abstract] [Full Text] [Related]

  • 28. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
    Zupi G, Marangolo M, Arancia G, Greco C, Laudonio N, Iosi F, Formisano G, Malorni W.
    Cancer Res; 1988 Nov 01; 48(21):6193-200. PubMed ID: 3167866
    [Abstract] [Full Text] [Related]

  • 29. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T, Marumo K.
    Int J Urol; 2004 Nov 01; 11(11):993-1000. PubMed ID: 15509204
    [Abstract] [Full Text] [Related]

  • 30. Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer.
    Cappelletti D, Cardillo A, Bonanno E, Prete SP, Cucchiara G, Turriziani M, Greiner JW, Cottarelli A, Breda E, Aquino A, Bonmassar E, De Vecchis L.
    J Exp Clin Cancer Res; 2000 Dec 01; 19(4):467-9. PubMed ID: 11277324
    [Abstract] [Full Text] [Related]

  • 31. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F.
    Eur J Cancer; 2009 Aug 01; 45(12):2219-27. PubMed ID: 19524433
    [Abstract] [Full Text] [Related]

  • 32. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H, Komura S, Ohishi N, Akiyama S, Kasai Y, Ito K, Nakao A, Yagi K.
    Anticancer Res; 2001 Aug 01; 21(5):3301-6. PubMed ID: 11848487
    [Abstract] [Full Text] [Related]

  • 33. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T.
    Cancer Res; 2001 Feb 01; 61(3):1029-37. PubMed ID: 11221829
    [Abstract] [Full Text] [Related]

  • 34. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
    Jordan A, Stein J.
    Eur J Nutr; 2003 Dec 01; 42(6):324-31. PubMed ID: 14673605
    [Abstract] [Full Text] [Related]

  • 35. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
    Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL.
    Cancer Res; 1990 Sep 15; 50(18):5735-9. PubMed ID: 1697499
    [Abstract] [Full Text] [Related]

  • 36. Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies.
    De Filippi R, Cucchiara G, Prete SP, Marini S, Ricci F, Nunziata C, Turriziani M, Bonmassar E, Fuggetta MP, De Vecchis L.
    Ann Oncol; 1991 Sep 15; 2(10):759-64. PubMed ID: 1801883
    [Abstract] [Full Text] [Related]

  • 37. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
    Schwartz EL, Baptiste N, O'Connor CJ, Wadler S, Otter BA.
    Cancer Res; 1994 Mar 15; 54(6):1472-8. PubMed ID: 8137250
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.
    Failli A, Consolini R, Legitimo A, Orsini G, Romanini A, Spisni R, Castagna M, Miccoli P.
    J Biol Regul Homeost Agents; 2011 Mar 15; 25(4):575-88. PubMed ID: 22217990
    [Abstract] [Full Text] [Related]

  • 39. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
    Okubo A, Sone S, Tanaka M, Ogura T.
    Cancer Res; 1989 Jan 15; 49(2):265-70. PubMed ID: 2463072
    [Abstract] [Full Text] [Related]

  • 40. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
    Fuggetta MP, D'Onofrio C, Bonmassar E.
    Ann Ist Super Sanita; 1990 Jan 15; 26(3-4):385-95. PubMed ID: 1708953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.